Review Article
The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease
Table 1
Association of anti-GP2 IgA and/or IgG with location of disease in CD.
| |||||||||||||||||||||||||||||||||||||||
Investigating the association of anti-GP2 IgA/IgG with different clinical phenotypes in CD, 11/16 of CD patients with ileocolonic location demonstrated anti-GP2 antibody positivity (P = 0.002). |